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The recent emergence of the human-pathogenic Vibrio
vulnificus in Israel was investigated by using multilocus
genotype data and modern molecular evolutionary analysis
tools. We show that this pathogen is a hybrid organism that
evolved by the hybridization of the genomes from 2 distinct
and independent populations. These findings provide clear
evidence of how hybridization between 2 existing and non-
pathogenic forms has apparently led to the emergence of
an epidemic infectious disease caused by this pathogenic
variant. This novel observation shows yet another way in
which epidemic organisms arise. 
V
ibrio vulnificus, a ubiquitous inhabitant of marine and
estuarine environments, is considered one of the most
dangerous waterborne pathogens. The case-fatality rate for
V. vulnificus septicemia may reach 50% (1). Human infec-
tion is generally acquired through eating contaminated raw
or undercooked seafood or through contamination of
wounds by seawater or marine animals (2). Infected per-
sons with preexisting liver disease, hemochromatosis, or
compromised immune systems are at particularly high risk
for fatal septicemia (3–8). 
Human infections are sporadic and almost entirely
caused by strains of biotype 1, while biotype 2 strains have
been reported to cause disease mainly among eels and
rarely infect humans (9). During the summer of 1996, a
major outbreak of systemic V. vulnificus infections started
among Israeli fish market workers and fish consumers
(10,11). Molecular studies showed that the disease out-
break was caused by a previously undescribed biotype that
exhibited a distinct phenotypic and molecular pattern, des-
ignated biotype 3 (11). 
The origins of this emergent infectious disease have not
been fully understood, although it was originally thought
to arise mostly from human behavior and work practices
(10). On the basis of these assumptions, new fish-handling
procedures were introduced (11,12). However, disease
continued, although at a lower incidence. Therefore, stud-
ies were undertaken to determine whether this novel out-
break of disease was caused by a specific lineage or clone.
The emergence of this new biotype could not be resolved
by conventional microbiologic and molecular typing
approaches. We investigated this outbreak by combining a




To study the emergence of this new biotype, we exam-
ined a collection of 159 V. vulnificus isolates that repre-
sented all 3 biotypes from human disease and
environmental sources that originated in Israel (n = 64),
the United States (n = 54), Denmark (n = 7), Germany (n
= 6), Spain (n = 5), Sweden (n = 5), Japan (n = 8), South
Korea (n = 2), Singapore (n = 2), Thailand (n = 1),
Indonesia (n = 1), and Taiwan (n = 1). In addition, 3 well-
characterized reference strains that represented the 3 bio-
types were included, the ATCC 27562 strain (biotype 1,
isolated from human blood in the USA), the E-39 strain
(biotype 2, isolated from diseased eel in Spain), and ATCC
BAA-86 (biotype 3, isolated from human blood in Israel).
Biotype 1 strains (n = 82) consisted of 39 isolates from
human disease and 43 environmental isolates; biotype 2
strains (n = 15) consisted of 13 isolates from diseased eels,
1 from an infected person, and 1 from diseased shrimp.
Biotype 3 strains were isolated from samples from persons
with invasive disease in Israel (n = 61) and from fish-pond
water (n = 3). Isolates were grown on blood agar plates and
incubated overnight at 35°C in aerobic conditions. The
lists of the isolates used in this study and their sources can
be accessed at http://pubmlst.org/vvulnificus. 
DNA Extraction
The DNeasy kit (QIAGEN GmbH, Hilden, Germany)
was used to extract DNA with the gram-negative bacterial
protocol as recommended by the manufacturer. Briefly,
several colonies from a bacterial culture were picked off
into phosphate-buffered saline solution and centrifuged at
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University, Ramat Aviv, Israel7,500 rpm (5,000 x g) for 10 min. The cell pellet was
resuspended in 180 µL of tissue lysis buffer, then 20 µLo f
proteinase K (10 mg/mL) was added, and the sample was
incubated at 55°C until the tissue was completely lysed.
Then 200 µL of lysis buffer was added and incubated at
70°C for 10 min. The DNAin the clear viscous lysates was
precipitated with ethanol 95% (vol/vol) and added to
DNeasy mini columns. Ethanol 70% (vol/vol)–based
buffers (AW1 and AW2) were added sequentially to the
columns and centrifuged at 8,000 rpm (6,000 x g). The
supernatants were discarded, and the DNAwas resuspend-
ed in AE buffer and used for amplification.
Multilocus Sequence Typing (MLST) 
This bacterium has 2 chromosomes. Fourteen house-
keeping genes (7 from each chromosome) that encoded
enzymes responsible for intermediary metabolism were
identified by searching the genome database
(http://www.ncbi.nlm.nih.gov/genomes/MICROBES/Com
plete.html) of V. vulnificus strain CMCP6, with gene
sequences from other bacteria. Genetic loci were chosen for
further investigation on the basis of the following criteria:
chromosomal location, suitability for primer design, and
sequence diversity in pilot studies. Ten loci were chosen for
the MLST scheme, 5 from each chromosome. The follow-
ing were chosen from the large chromosome: glp, the
encoding glucose-6-phosphate isomerase; gyrB, the encod-
ing DNA gyrase-subunit B; mdh, the encoding malate-lac-
tate dehydrogenase; metG, the encoding methionyl-tRNA
synthetase; and purM, the encoding phosphoribosy-
laminoimidazole synthetase. The following were chosen
from the small chromosome: dtdS, the encoding threonine
dehydrogenase; lysA, the encoding diaminopimelate decar-
boxylase; pntA, the encoding transhydrogenase alpha sub-
unit;  pyrC, the encoding dihydroorotase; and tnaA, the
encoding tryptophanase. Their chromosomal location sug-
gested that it was unlikely for any of the loci to be coinher-
ited in the same recombination event, as the minimum
distance between loci was 300 kb (Table). 
Amplification and Nucleotide Sequence Determination
Polymerase chain reaction (PCR) products were ampli-
fied with oligonucleotide primer pairs designed from the
V. vulnificus genome sequence. These primers provided
reliable amplification from a diverse range of samples
(available from http://pubmlst.org/vvulnificus). Each 50-
µL amplification reaction mixture was made up of 10 ng
of V. vulnificus chromosomal DNA, 100 pmol of each
PCR primer (MWG Biotech, Ebersberg, Germany), 10 x
PCR buffer with 1.5 mmol/L MgCl2 (QIAGEN GmbH),
0.5 U of Taq DNApolymerase (QIAGEN GmbH), and 1.6
mmol/L deoxynucleoside triphosphates (ABgene, Epsom,
UK). The reaction conditions were denaturation at 94°C
for 1 min, primer annealing at 50°C for 45 s and extension
at 72°C for 1 min for 30 cycles. The amplification prod-
ucts were purified by precipitation with 20% polyethylene
glycol and 2.5 mol/L NaCl (14), and their nucleotide
sequences were determined at least once on each DNA
strand by using internal nested primers (available from
http://pubmlst.org/vvulnificus) and ABI PRISM BigDye
Terminators v 3.0 Reaction Mix (Applied Biosystems,
Foster City, CA) in accordance with the manufacturer’s
instructions. Unincorporated dye terminators were
removed by precipitation ofthe termination products with
sodium acetate (3 mol/L, pH 5.2) and 95% ethanol, and
the reaction productswere separated and detected with an
ABI PRISM  3730 DNAAnalyzer (Applied Biosystems).
Sequences were assembled from the resultant chro-
matograms with the STADEN suite of computerprograms
and edited to resolve any ambiguities (15). For each locus,
every different sequence was assigned a distinct allele
number in order of identification; these sequences were
internal fragments of the gene, which contained an exact
number of codons. Each isolate was therefore designated
by a 10-integer number (the allelic profile), which corre-
sponds to the allele numbers at the 10 loci in the follow-
ing order: glp, gyrB, mdh, metG, purM, dtdS, lysA, pntA,
pyrC, and tnaA. Isolates with the same allelic profile are
assigned to the same sequence type (ST), which were
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and so on). The data have been deposited(http://pubmlst.
org/vvulnificus). 
Inferring the Population Structure 
and Ancestral Sources 
The program STRUCTURE was used to define the pop-
ulation structure and identify the ancestral sources of the 10
gene fragments from all the strains. STRUCTURE is a
recently developed program that implements a Bayesian
model approach for inferring population structure and
ancestral sources from multilocus genotype data (16). Of
the 4,326 nucleotides sequenced for each isolate from the
10 genes, 447 nt were polymorphic. For the purposes of the
analysis, these nucleotides were used by STRUCTURE as
individual loci. STRUCTURE can infer the population
structure by using a variety of models, including the link-
age model (17), which incorporates linkage disequilibrium
due to correlations in ancestry between loci that reflects
admixture between populations. This approach has recent-
ly been used to elucidate the structure and evolution of
populations of the human pathogen Helicobacter pylori
(18), and we have used the same method here. For the pur-
poses of the analysis, the nucleotide sequence of the 10
housekeeping gene fragments of 2 clinical strains of V. vul-
nificus, CMCP6 and YJ016,  whose complete genome
sequence has been recently completed (http://www.ncbi.
nlm.nih.gov/genomes/ MICROBES/Complete.html), were
added to all the data sets.
Results
Genotypes Identified
The 159 isolates were resolved into 70 STs, 56 of which
were present only once in the entire collection. Eighty-two
isolates (51.6%) were represented by 1 of 4 STs: ST-8 was
the most common and occurred 62 times (39%); ST-6
occurred in 11 isolates (6.9%); ST-32 occurred in 5 isolates
(3.1%); ST-16 occurred in 4 isolates (2.5%). The remain-
ing 21 isolates resolved into 10 sequence types. Strains of
biotype 1 (n = 82) resolved into 66 STs. Biotype 2 (15 iso-
lates) resolved into 4 STs; ST-6, ST-9, ST-10, and ST-48.
ST-6 was the most common, occurring 11 times and con-
sisting of all the indole-negative isolates. All biotype 3
strains (n = 62) were genetically identical and belonged to
ST-8.
Population Structure and Ancestral Sources
The observed sequence variation between the 2 chro-
mosomes was comparable. Initial analysis of sequence
data from the 10 gene fragments showed that extensive
recombination had occurred within all the genetic loci
under study (data not shown). Constructing phylogenetic
trees in the presence of recombination is problematic
because different parts of the sequence may have different
phylogenetic histories. Therefore, we analyzed the data
with the program STRUCTURE. First, we tested the
assumption that the 3 V. vulnificus biotypes represent 3 dis-
tinct predetermined populations of this pathogen (K = 3).
The results of multiple analyses with STRUCTURE were
incompatible with this assumption; in all cases, only 2
populations were identified, populations Aand B (Figure 1
and data not shown). Further, while biotype 1 was present
in both populations, biotype 2 was present only in popula-
tion A (Figure 1A). Biotype 3 occupied an intermediate
position between the 2 populations (Figure 1A). Figure 1B
shows that an overrepresentation of human disease isolates
occurred in population B and an overrepresentation of
environmental isolates occurred in population A. And
Figure 1C shows that both populations were globally dis-
tributed. 
To identify the evolutionary processes underlying the
emergence of the genotype responsible for the Israeli out-
break, we repeated the STRUCTURE analysis assuming
only 2 populations (K = 2) (based on the findings from the
first STRUCTURE analysis). This analysis identified the
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Figure 1. Triangle plots of STRUCTURE results. Only 2 populations were identified (A and B).  A shows the distribution of the biotypes
within the 2 populations. B shows the distribution of the strains according to their source (human or environmental). C shows the strains’
distribution according to their geographic origin. These results were produced by the linkage model of STRUCTURE with K = 3.ancestral sources of the individual strains (Figure 2). Each
strain is represented by a thin vertical line partitioned into
2 (K = 2) most likely predetermined populations or genet-
ic ancestries. Each line shows the proportion of polymor-
phic sites inherited from each of the 2 populations (shown
in green and red). It shows that most biotype 1 and 2
strains have predominant contribution from 1 of the 2
genetic ancestries. However, strains of biotype 3 have
almost equal contributions from both genetic ancestries.
This analysis was further detailed to identify the ancestral
sources of each of the polymorphic sites in each of the 10
gene fragments (Figure 3).These analyses confirmed that,
notwithstanding the subdivision of V. vulnificus popula-
tions into 2 populations, recombination had occurred
between these populations and that the Israeli outbreak
genotype is a hybrid, with some genes originating from 1
population and some from another, while some genes have
representation from both. 
Discussion
We have shown that a hybrid virulent organism that
acquired genes from 2 distinct and independent popula-
tions has caused the disease outbreak in Israel. To achieve
this analysis, we studied large, carefully assembled, col-
lections of V. vulnificus isolates. The human strains were
collected from infected patients in Israel, the United States,
Europe, and Southeast Asia. The environmental strains
were collected from environmental sources in the United
States, the Pacific Ocean, the Baltic Sea, inland fish farms
in Israel, and eel farms in Europe. 
The division of V. vulnificus populations into 2 major
groups is consistent with results of multilocus enzyme
electrophoresis studies (19). However, those studies placed
the Israeli electrophoretic type within 1 of the 2 groups, in
contrast to our findings, which placed the Israeli genotype
in an intermediate position between the 2 populations
(Figure 1A and Figure 3). 
Hybridization within bacterial populations, i.e., the
process whereby a hybrid results from the hybridization of
the genomes of 2 or more populations of a species or an
organism, has been the focus of much attention by scien-
tists in the last decade (20–25); these events, which may be
intra- or interspecies, could alter the genetic distances and
the phylogenetic relationships within bacterial popula-
tions. The magnitude by which these events occur is cru-
cially dependent on ecologic factors; different populations
of a species must be present within the same niche for
genetic exchange to have an impact on genetic variation
(26). Multiple sampling of fish-farm water and fish docu-
mented the abundance of biotype 1 strains (11 and data not
shown). These biotype 1 strains, representing both popula-
tions of V. vulnificus, were never implicated in disease
among fish-farm fish, according to the Central Fish Health
Laboratory, Kibbutz Nir David, Israel (www.moag.gov.il/
english), or among humans in Israel (11). These observa-
tions are consistent with finding that these populations are
not pathogenic to either humans or fish. The finding that
this hybrid variant (biotype 3) was the only implicated
organism in all disease cases from 1995 to 2003 is indica-
tive of its pathogenicity. Furthermore, the finding that all
62 biotype 3 strains were genetically identical could sug-
gest that this hybrid clone may have evolved by a relative-
ly recent genome hybridization event.
Hybrid variants have been recently described among
populations of Staphylococcus aureus (27) and Chlamydia
trachomatis (28). However, our findings show the first
bacterial variant that is clearly more pathogenic than the
existing forms of the organism, i.e., the Israeli hybrid
clone, is more pathogenic than the existing biotype 1
strains within the Israeli aquaculture system. These find-
ings are consistent with observations among influenza
viruses (29). This phenomenon has also recently been
described also among populations of mosquitoes (30), in
which hybridization between existing forms of a relatively
nonpathogenic organism has apparently led to the emer-
gence of a novel pathogenic variant that poses a particular
threat to human health. 
The Israeli genotype spread extensively after its emer-
gence in 1995, and by 2003, most of the fish farms in Israel
were the sources of V. vulnificus cases. This finding is con-
sistent with the idea that this pathogen is circulating freely
within the underground brackish water reservoirs that sup-
ply these fish farms. Despite the widespread use of inland
fish farming around the world, no similar outbreaks have
been reported. During the 1970s and 1980s, the introduc-
tion into Israel of stocks of Tilapia spp. from Africa, the
Far East, and South America (31–33) (for experimental
and commercial purposes) may have contributed to the
Hybrid Vibrio vulnificus
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Figure 2. Results of a Bayesian cluster analysis by STRUCTURE.
Each of the strains included in the analysis is represented by a thin
vertical line, partitioned into 2 colored segments that represent the
proportion of polymorphic sites inherited from each of the 2 genet-
ic ancestries. For the representation of results, strains were
grouped according to biotype. The analysis was carried out by
using the linkage model with K = 2.evolution of this hybrid clone. In view of the widespread
fish-trading industry, this hybrid clone may eventually
emerge through exports of Israeli tilapia stocks, in remote
geographic locations. In conclusion, these observations
demonstrate the power of molecular and population genet-
ic approaches in investigating the emergence of a novel
pathogen and defining its nature. Our results show another
way by which epidemic infectious diseases arise. 
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